Spores of Mucor ramosissimus, Mucor plumbeus and Mucor circinelloides and their ability to activate human complement system in vitro

Medical Mycology

Volumn 48, Issue 2, 2010, Pages 278-284

  Granja, Luiz Fernando Zmetek ^a   Pinto, Lysianne ^a   Almeida, Cátia Amancio ^a   Alviano, Daniela Sales ^a   Da Silva, Maria Helena ^a   Ejzemberg, Regina ^a   Alviano, Celuta Sales ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Complement system; Fungi; Mucor circinelloides; Mucor plumbeus; Mucor ramosissimus; Spores; Zygomycetes

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; EDETIC ACID; EGTAZIC ACID; IMMUNOGLOBULIN G; MAGNESIUM; MANNAN BINDING LECTIN; MANNOSE BINDING LECTIN;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGUS; FUNGUS SPORE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; MUCOR CIRCINELLOIDES; MUCOR PLUMBEUS; MUCOR RAMOSISSIMUS; NONHUMAN; SERUM; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; METABOLISM; MUCOR; PHYSIOLOGY;

FUNGI; MUCOR CIRCINELLOIDES; MUCOR PLUMBEUS; MUCOR RAMOSISSIMUS; ZYGOMYCETES;

C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C4; EDETIC ACID; EGTAZIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOGLOBULIN G; MANNOSE-BINDING LECTIN; MUCOR; SPORES, FUNGAL;

EID: 76649113753     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903096669     Document Type: Article

References (41)

1. Speth C, Rambach G, Wurzner R, Lass-Florl C. Complement and fungal pathogens: an update. Mycoses 2008; 51: 477-496.
2. Runza VL, Schwaeble W, Mannel DN. Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008; 213: 297-306.
3. Abdel-Hafez SII. Composition of fungal flora of four cereal grains in Saudi Arabia. Mycopathologia 1984; 85: 53-57.
4. Alonso A, Rodriguez SR, Rodriguez SM, et al. Intersticial pneumonites induced in guinea pigs by the antigens of Rhizopus nigricans. J Investig Allergol Clin Immunol 1997; 7: 103-109.
5. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215-229.
6. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; S1: 31-47.
7. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 2002; 16: 895-914.
8. Chan-Tack KM, Nemoy LL, Perencevich EN. Central venous catheterassociated fungemia secondary to mucormycosis. Scand J Infect Dis 2005; 37: 925-927.
9. Chandra S, Woodgyer A. Primary cutaneous zygomycosis due to Mucor circinelloides. Australas J Dermatol. 2002; 43: 39-42.
10. Iwen PC, Sigler L, Noel RK, Freifeld AG. M ucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J Clin Microbiol 2007; 45: 636-640.
11. Bullock JD, Jampol LM, Fezza AJ. Two cases of orbital phycomycosis with recovery. Am J Ophthalmol 1974; 78: 811-815.
12. Vignale R, Mackinnon JE, Casella De Vilaboa E, Burgoa F. Chronic, destructive, mucocutaneous phycomycosis in man. Sabouraudia 1964; 3: 143-147.
13. Weitzman I, Della-Latta P, Housey G, Rebatta G. Mucor ramosissimus Samutsevitsch isolated from a thigh lesion. J Clin Microbiol 1993; 31: 2523-2525.
14. Areche C, Loyola LA, Borquez J, Rovirosa J, San-Martin A. Microbial transformation of the diterpene mulin-11,13-dien-20-oic acid by Mucor plumbeus. Magn Reson Chem 2008; 46: 765-768.
15. Wang Y, Tan TK, Tan GK, Connolly JD, Harrison LJ. Microbial transformation of the sesquiterpenoid (-)-maalioxide by Mucor plumbeus. Phytochem. 2006; 67: 58-61.
16. Marx RS, Forsyth KR, Hentz SK. M ucorales species activation of a serum leukotactic factor. Infect Immun 1982; 38: 1217-1222.
17. Lima AO, Silva WD. Imunologia, Imunopatologia, Alergia-Méto-dos, 1st ed. Rio de Janeiro: Guanabara Koogan, 1970.
18. Mayer MM. Chapter 4: Complement and complement fixation. In: Kabat EA, Mayer MM (eds). Experimental Immunochemistry, 2nd ed. Springfield: Thomas Publisher, 1961; 133-240.
19. Voller A, Bidwell DE. Enzyme-linked immunosorbent assay. In: Rose NR, Friedman H, Faley J (eds). Manual of Clinical Laboratory Immunology, 3rd edn. Washington, DC: American Society for Microbiology, 1986.
20. Fine DP. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun 1975; 12: 772-778.
21. Bouza E, Munoz P, Guinea J. Mucormycosis: an emerging disease? Clin Microbiol Infect 2006; 12: 7-23.
22. Kozel TR. Complement activation by pathogenic fungi. Res Immunol 1998; 149: 309-320.
23. Pinto MR, Melillo D, Giacomelli S, Sfyroera G, Lambris JD. Ancient origin of the complement system: emerging invertebrate models. Adv Exp Med Biol 2007; 598: 372-388.
24. Zhu Y, Thangamani S, Ho B, Ding JL. The ancient origin of the complement system. EMBO J 2005; 24: 382-394.
25. Smith LC, Clow LA, Terwilliger DP. The ancestral complement system in sea urchins. Immunol Rev 2001; 180: 16-34.
26. Ahearn JM, Fearon DT. Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv Immunol 1989; 46: 183-219.
27. Rosen H, Law SKA. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr Top Microbiol Immunol 1990; 153: 99-122.
28. Law SK, Minich TM, Levine RP. Binding reaction between the third human complement protein and small molecules. Biochemistry 1981; 20: 7457-7463.
29. Kozel TR, Brown RR, Pfrommer GS. Activation and binding of C3 by Candida albicans. Infect Immun 1987; 55: 1890-1894.
30. Kozel TR, Wilson MA, Farrel TP, Levitz SM. Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect Immun 1989; 57: 2412-2417.
31. Young BJ, Kozel TR. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect Immun 1993; 61: 2966-2972.
32. Zhang MX, Klein B. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis. Infect Immun 1997; 65: 1849-1855.
33. Granja LFZ, Pinto L, Alviano DS, et al. Activation of human complement system by Mucor polymorphosporus mycelia. The Open Mycol J 2008; 2: 94-99.
34. Gadjeva MG, Rouseva MM, Zlatarova AS, e t al. Interaction of Human C1q with IgG and IgM: Revisited. Biochemistry 2008; 47: 13093-13102.
35. Casey R, Newcombe J, McFadden J, Bodman-Smith KB. The acutephase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun 2008; 76: 1298-1304.
36. Sobota A, Strzelecka-Kiliszek A, Gladkowska E, e t al. Binding of IgG-opsonized particles to Fc gamma R is an active stage of phagocytosis that involves receptor clustering and phosphorylation. J Immunol 2005; 175: 4450-4457.
37. Mold C, Du Clos TW. C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors. J Immunol 2006; 176: 7598-7604.
38. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007; 171: 715-727.
39. Gutzmer R, Kother B, Zwirner J, et al. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol 2006; 126: 2422-2429.
40. Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin - a soluble pattern recognition molecule. Mol Immunol 2004; 41: 113-121. (Pubitemid 38678615)
41. Bartnicki-Garcia S. Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 1968; 22: 87-108.